Atlas Trials

Alirocumab and Reverse Cholesterol Transport

Clinical trial NCT03014830 · COMPLETED

Trial details

NCT number
NCT03014830
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
AtherosclerosisCoronary Heart Disease
Start date
2017-06-01
Primary completion
2018-06-04
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.